Gain an end-to-end outlook on the entire journey of gene therapy development, with 5 tracks exploring the discovery, clinical trial, manufacturing, and commercialisation of gene therapies.

Tackle the latest challenges in our interactive sessions featuring panel discussions and roundtables, addressing pressing issues such as vector design, gene engineering, preparing for regulatory changes, and more

Benefit from real-world case studies presented by industry experts, including insights into how to navigate regulatory submission, as well as operationalising clinical trials

Acquire practical solutions to overcome obstacles in the development and production of gene therapies, with opportunities to meet with and hear from vendor companies

• Delve into critical issues in cell culture, cell line development, and bioprocessing. Engage with presentations and interactive sessions aimed at translating research discoveries into safe and effective therapies for patients
  
  
• Embark on a journey through CGT development and commercialisation. Explore the latest advancements and challenges presented by industry leaders across tracks covering clinical trial design, regulatory matters, and IP challenges
  
  
• Fast-track your CGT manufacturing pipeline by connecting with and learning from innovators pushing the boundaries of therapy manufacture. Topics span from supply chain logistics to considerations between autologous and allogenic therapies.